Date: December 01, 2022
Time: 7:00am (PST), 10:00am (EST), 4:00pm (CET)
Achievement of the UNAIDS 95-95-95 targets by country are in danger due to significant variability in progress across populations and countries. Gaps are attributed to reaching vulnerable youth and key populations and ensuring equitable access to testing and treatment. Due to colliding pandemics, a robust testing infrastructure is of critical importance to manage existing programmatic needs while scaling up testing and supporting pandemic preparedness efforts. To support countries in closing these gaps, and get back on track, new guidance has been released in the form of the WHO key populations guidance as well as the PEPFAR Strategic Direction: Fulfilling America’s Promise to End the HIV/AIDS Pandemic by 2030. Implementation of the new guidance requires a coordinated effort across health system stakeholders to optimize the clinical cascade and achieve the UNAIDS 95-95-95 targets. Join Dr. Deborah Birx and an esteemed global panel to discuss critical HIV/AIDS programmatic aspects that currently hinder progress and debate what requirements are needed for getting back on track.
- Explain the importance of evolving policies to increasing programmatic impact and equity based on data from the field
- The importance of the recent guidelines and their potential impact to HIV/AIDS programs
- Discuss the implementation requirements to break down barriers that hamper progress in the global HIV response
- Review the global health sector strategies on, HIV, viral hepatitis, and sexually transmitted infections and debate adapting in country testing infrastructures to the new realities of testing integration for HIV, STIs and Viral Hepatitis
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.
© 2022 Abbott. All rights reserved.